Family history of hypertension and cardiovascular risk factors in prepubertal children

American Journal of Hypertension

Volumn 23, Issue 3, 2010, Pages 299-304

  Rodríguez Moran, Martha ^a,b   Aradillas García, Celia ^c   Simental Mendia, Luis E ^a,b   Monreal Escalante, Elizabeth ^c   De La Cruz Mendoza, Esperanza ^c   Dávila Esqueda, Maria E ^c   Guerrero Romero, Fernando ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Research Group on Diabetes and Chronic Illnesses   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Blood pressure; Cardiovascular risk factors; Family history of hypertension; Hyperinsulinemia; Hypertension

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR RISK; CHILD; FAMILY HISTORY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WAIST CIRCUMFERENCE;

ADOLESCENT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FAMILY; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; HYPERTENSION; MALE; METABOLIC SYNDROME X; MEXICO; PEDIGREE; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 76749100656     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.257     Document Type: Article

References (43)

1. Spangler JG, Bell RA, Summerson JH, Konen JC. Hyperinsulinemia in hypertension: associations with race, abdominal obesity, and hyperlipidemia. Arch Fam Med 1998; 7:53-56.
2. Criqui MH. Obesity, risk factors, and predicting cardiovascular events. Circulation 2005; 111:1869-1870.
3. Nambi V, Hoogwerf BJ, Sprecher DL. A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia. Cleve Clin J Med 2002; 69:985-989.
4. Kekäläinen P, Sarlund H, Pyörälä K, Laakso M. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care 1999; 22:86-92.
5. Lopes HF, Silva HB, Soares JA, Filho B, Consolim-Colombo FM, Giorgi DM, Krieger EM. Lipid metabolism alterations in normotensive subjects with positive family history of hypertension. Hypertension 1997; 30:629-631.
6. Ferrari P, Weidmann P, Shaw S, Giachino D, Riesen W, Allemann Y, Heynen G. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 1991; 91:589-596.
7. Facchini F, Chen YD, Clinkingbeard C, Jeppesen J, Reaven GM. Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 1992; 5:694-699.
8. Grunfeld B, Balzareti M, Romo M, Gimenez M, Gutman R. Hyperinsulinemia in normotensive offspring of hypertensive parents. Hypertension 1994; 23: I12-I15.
9. Beatty OL, Harper R, Sheridan B, Atkinson AB, Bell PM. Insulin resistance in offspring of hypertensive parents. BMJ 1993; 307: 92-96.
10. Grandi AM, Gaudio G, Fachinetti A, Zanzi P, Bianchi L, Ceriani L, Guasti L, Venco A. Influence of family history of hypertension on insulin sensitivity in lean and obese hypertensive subjects. Eur J Clin Invest 1997; 27:774-779.
11. Grandi AM, Gaudio G, Fachinetti A, Bianchi L, Nardo B, Zanzi P, Ceriani L, Guasti L, Venco A. Hyperinsulinemia, family history of hypertension, and essential hypertension. Am J Hypertens 1996; 9:732-738.
12. von Eiff AW, Gogolin E, Jacobs U, Neus H. Ambulatory blood pressure in children followed for 3 years. Influence of sex and family history of hypertension. Clin Exp Hypertens A 1986; 8:577-581.
13. Munger RG, Prineas RJ, Gomez-Marin O. Persistent elevation of blood pressure among children with a family history of hypertension: the Minneapolis Children's Blood Pressure Study. J Hypertens 1988; 6:647-653.
14. Himmelmann A, Svensson A, Hansson L. Five-year follow-up of blood pressure and left ventricular mass in children with different maternal histories of hypertension: the Hypertension in Pregnancy Offspring Study. J Hypertens 1994; 12:89-95.
15. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child 1966; 41:454-471.
16. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003; 157:821-827.
17. Almeida CA, Pinho A P, Ricco RG, Pepato MT, Brunetti IL. Determination of glycemia and insulinemia and the homeostasis model assessment (HOMA) in schoolchildren and adolescents with normal body mass index. J Pediatr (Rio J) 2008; 84:136-140.
18. Li C, Ford ES, Mokdad AH, Cook S. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics 2006; 118:e1390-e1398.
19. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl 4th Report): 555-576.
20. Hirschler V, Aranda C, Calcagno Mde L, Maccalini G, Jadzinsky M. Can waist circumference identify children with the metabolic syndrome? Arch Pediatr Adolesc Med 2005; 159:740-744.
21. Eisenmann JC. Waist circumference percentiles for 7-to 15-year-old Australian children. Acta Paediatr 2005; 94:1182-1185.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
23. Saely CH, Aczel S, Marte T, Langer P, Hoefle G, Drexel H. The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients. J Clin Endocrinol Metab 2005; 90:5698-5703.
24. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007; 49:2112-2119.
25. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocr Rev 2008; 29:777-822.
26. Thomas F, Balkau B, Vauzelle-Kervroedan F, Papoz L. Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study Group. Diabetes 1994; 43:63-67.
27. Suzuki Y, Suzuki S, Hinokio Y, Chiba M, Atsumi Y, Hosokawa K, Shimada A, Asahina T, Matsuoka K. Diabetes associated with a novel 3264 mitochondrial tRNA(Leu)(UUR) mutation. Diabetes Care 1997; 20:1138-1140.
28. Byrne EM, McRae AF, Duffy DL, Zhao ZZ, Martin NG, Whitfield JB, Visscher PM, Montgomery GW. Family-based mitochondrial association study of traits related to type 2 diabetes and the metabolic syndrome in adolescents. Diabetologia 2009; e-pub ahead of print 4 September 2009.
29. Liu Y, Li R, Li Z, Wang XJ, Yang L, Wang S, Guan MX. Mitochondrial transfer RNAMet 4435A>G mutation is associated with maternally inherited hypertension in a Chinese pedigree. Hypertension 2009; 53:1083-1090.
30. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton R P. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004; 306:1190-1194.
31. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 2000; 283:221-228.
32. Maxwell AJ, Bruinsma KA. Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 2001; 38:1850-1858.
33. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24:816-823.
34. De Caterina R, Zampolli A, Del Turco S, Madonna R, Massaro M. Nutritional mechanisms that influence cardiovascular disease. Am J Clin Nutr 2006; 83: 421S-426S.
35. Frohlich ED. The salt conundrum: a hypothesis. Hypertension 2007; 50:161-166.
36. Guerrero-Romero F, Rodríguez-Morán M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002; 39:209-213.
37. Guerrero-Romero F, Rodríguez-Morán M. Hypomagnesemia, oxidative stress, inflammation, and metabolic syndrome. Diabetes Metab Res Rev 2006; 22: 471-476.
38. Lima Mde L, Cruz T, Rodrigues LE, Bomfim O, Melo J, Correia R, Porto M, Cedro A, Vicente E. Serum and intracellular magnesium deficiency in patients with metabolic syndrome-evidences for its relation to insulin resistance. Diabetes Res Clin Pract 2009; 83: 257-262.
39. Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/ neurogenic inflammation hypothesis. Am J Physiol 1992; 263(3 Pt 2): R734-R737.
40. Song Y, Li T Y, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007; 85:1068-1074.
41. Guerrero-Romero F, Rodríguez-Morán M. Prevalence of dyslipidemia in non-obese prepubertal children and its association with family history of diabetes, high blood pressure, and obesity. Arch Med Res 2006; 37:1015-1021.
42. Rodríguez-Morán M, Guerrero-Romero F. Hyperinsulinemia in healthy children and adolescents with a positive family history for type 2 diabetes. Pediatrics 2006; 118:e1516-e1522.
43. Guerrero-Romero F, Rodríguez-Morán M, González-Ortiz M, Martínez-Abundis E. Early decrease of the percent of HOMA beta-cell function is independently related to family history of diabetes in healthy young nonobese individuals. Diabetes Metab 2005; 31:382-386.